How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy?
High-grade T1 bladder cancer has a poor prognosis due to a higher incidence of recurrence and progression than other nonmuscle invasive bladder cancer; thus patients with high-grade T1 have to be carefully monitored and managed. If patients are diagnosed with high-grade T1 at initial transurethral...
Main Authors: | Seok Joong Yun, Seon-Kyu Kim, Wun-Jae Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2016-06-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-57-S44.pdf |
Similar Items
-
Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
by: Yong-June Kim, et al.
Published: (2016-06-01) -
Bladder preservation in muscle-invasive bladder cancer: a comprehensive review
by: Judy Hamad, et al.
Published: (2020-02-01) -
Prominence of urinary biomarkers for bladder cancer in the COVID-19 era: From the commercially available to new prospective candidates
by: Xuan-Mei Piao, et al.
Published: (2021-09-01) -
Aberrantly expressed microRNAs in the context of bladder tumorigenesis
by: Jong-Young Lee, et al.
Published: (2016-06-01) -
External validation of European Association of Urology NMIBC risk scores to predict progression after transurethral resection of bladder tumor in Korean patients with non-muscle-invasive bladder cancer
by: Jae Yeon Kim, et al.
Published: (2022-09-01)